Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164882491> ?p ?o ?g. }
- W3164882491 endingPage "353" @default.
- W3164882491 startingPage "343" @default.
- W3164882491 abstract "This study aims to retrospectively assess C-lectin-like molecule 1 (CLL-1) bimodal expression on CD34+ blasts in acute myeloid leukemia (AML) patients (total N = 306) and explore potential CLL-1 bimodal associations with leukemia and patient-specific characteristics.Flow cytometry assays were performed to assess the deeper immunophenotyping of CLL-1 bimodality. Cytogenetic analysis was performed to characterize the gene mutation on CLL-1-negative subpopulation of CLL-1 bimodal AML samples.The frequency of a bimodal pattern of CLL-1 expression of CD34+ blasts ranged from 8% to 65% in the different cohorts. Bimodal CLL-1 expression was most prevalent in patients with MDS-related AML (P = .011), ELN adverse risk (P = .002), NPM1 wild type (WT, P = .049), FLT3 WT (P = .035), and relatively low percentages of leukemia-associated immunophenotypes (P = .006). Additional immunophenotyping analysis revealed the CLL-1- subpopulation may consist of pre-B cells, immature myeloblasts, and hematopoietic stem cells. Furthermore, (pre)-leukemic mutations were detected in both CLL-1+ and CLL-1- subfractions of bimodal samples (N = 3).C-lectin-like molecule 1 bimodality occurs in about 25% of AML patients and the CLL-1- cell population still contains malignant cells, hence it may potentially limit the effectiveness of CLL-1-targeted therapies and warrant further investigation." @default.
- W3164882491 created "2021-06-07" @default.
- W3164882491 creator A5002232174 @default.
- W3164882491 creator A5014024833 @default.
- W3164882491 creator A5015912578 @default.
- W3164882491 creator A5016772237 @default.
- W3164882491 creator A5017161446 @default.
- W3164882491 creator A5018592613 @default.
- W3164882491 creator A5020528788 @default.
- W3164882491 creator A5025709796 @default.
- W3164882491 creator A5034203177 @default.
- W3164882491 creator A5034670444 @default.
- W3164882491 creator A5035965636 @default.
- W3164882491 creator A5038836803 @default.
- W3164882491 creator A5057088387 @default.
- W3164882491 creator A5060452476 @default.
- W3164882491 creator A5061895156 @default.
- W3164882491 creator A5070729528 @default.
- W3164882491 creator A5071733656 @default.
- W3164882491 creator A5072492355 @default.
- W3164882491 creator A5076242051 @default.
- W3164882491 creator A5079925537 @default.
- W3164882491 creator A5080686473 @default.
- W3164882491 creator A5089793203 @default.
- W3164882491 date "2021-06-26" @default.
- W3164882491 modified "2023-09-27" @default.
- W3164882491 title "Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients" @default.
- W3164882491 cites W1755891471 @default.
- W3164882491 cites W1976003936 @default.
- W3164882491 cites W1997412169 @default.
- W3164882491 cites W2024763401 @default.
- W3164882491 cites W2082484676 @default.
- W3164882491 cites W2093144236 @default.
- W3164882491 cites W2113753666 @default.
- W3164882491 cites W2127031140 @default.
- W3164882491 cites W2128541003 @default.
- W3164882491 cites W2136882360 @default.
- W3164882491 cites W2152223141 @default.
- W3164882491 cites W2163270535 @default.
- W3164882491 cites W2168342352 @default.
- W3164882491 cites W2290517386 @default.
- W3164882491 cites W2509914352 @default.
- W3164882491 cites W2558279374 @default.
- W3164882491 cites W2563784492 @default.
- W3164882491 cites W2593283932 @default.
- W3164882491 cites W2621998980 @default.
- W3164882491 cites W2765972717 @default.
- W3164882491 cites W2783779434 @default.
- W3164882491 cites W2791337382 @default.
- W3164882491 cites W2794480810 @default.
- W3164882491 cites W2806542645 @default.
- W3164882491 cites W2883212521 @default.
- W3164882491 cites W2898794856 @default.
- W3164882491 cites W2903615768 @default.
- W3164882491 cites W2904525744 @default.
- W3164882491 cites W2911721699 @default.
- W3164882491 cites W2943245179 @default.
- W3164882491 cites W2947566808 @default.
- W3164882491 cites W2957607325 @default.
- W3164882491 cites W2971056657 @default.
- W3164882491 cites W3093542900 @default.
- W3164882491 cites W3117401843 @default.
- W3164882491 cites W4254687493 @default.
- W3164882491 doi "https://doi.org/10.1111/ejh.13672" @default.
- W3164882491 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8457079" @default.
- W3164882491 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34053123" @default.
- W3164882491 hasPublicationYear "2021" @default.
- W3164882491 type Work @default.
- W3164882491 sameAs 3164882491 @default.
- W3164882491 citedByCount "3" @default.
- W3164882491 countsByYear W31648824912021 @default.
- W3164882491 countsByYear W31648824912022 @default.
- W3164882491 crossrefType "journal-article" @default.
- W3164882491 hasAuthorship W3164882491A5002232174 @default.
- W3164882491 hasAuthorship W3164882491A5014024833 @default.
- W3164882491 hasAuthorship W3164882491A5015912578 @default.
- W3164882491 hasAuthorship W3164882491A5016772237 @default.
- W3164882491 hasAuthorship W3164882491A5017161446 @default.
- W3164882491 hasAuthorship W3164882491A5018592613 @default.
- W3164882491 hasAuthorship W3164882491A5020528788 @default.
- W3164882491 hasAuthorship W3164882491A5025709796 @default.
- W3164882491 hasAuthorship W3164882491A5034203177 @default.
- W3164882491 hasAuthorship W3164882491A5034670444 @default.
- W3164882491 hasAuthorship W3164882491A5035965636 @default.
- W3164882491 hasAuthorship W3164882491A5038836803 @default.
- W3164882491 hasAuthorship W3164882491A5057088387 @default.
- W3164882491 hasAuthorship W3164882491A5060452476 @default.
- W3164882491 hasAuthorship W3164882491A5061895156 @default.
- W3164882491 hasAuthorship W3164882491A5070729528 @default.
- W3164882491 hasAuthorship W3164882491A5071733656 @default.
- W3164882491 hasAuthorship W3164882491A5072492355 @default.
- W3164882491 hasAuthorship W3164882491A5076242051 @default.
- W3164882491 hasAuthorship W3164882491A5079925537 @default.
- W3164882491 hasAuthorship W3164882491A5080686473 @default.
- W3164882491 hasAuthorship W3164882491A5089793203 @default.
- W3164882491 hasBestOaLocation W31648824912 @default.
- W3164882491 hasConcept C10205521 @default.
- W3164882491 hasConcept C104317684 @default.